Buy or sell Navigenics stock pre IPO via an EquityZen fund

EquityZen is a marketplace for shares of proven pre IPO tech companies


Navigenics Stock

Personal genomics

About Navigenics Stock

Navigenics, Inc. helps educate and empower individuals and their physicians with knowledge of their genetic predispositions, and then motivates them to act on the information to prevent the onset of disease, achieve earlier diagnosis, appropriately manage disease, or otherwise lessen its impact. Navigenics' lead investors are Kleiner Perkins Caufield and Byers, Sequoia Capital and MDV-Mohr Davidow Ventures.

Funding History

November 2007$25.0M
February 2010$18.0M



David B. Agus

Co-Founder, Chief Science officer

Dietrich Stephan


Vance Vanier


Matthew Garrett

EquityZen does not have an affiliation with, formal relationship with, or endorsement from any companies featured above. This profile is based on publicly available information and is intended to be informative in nature.

Some data provided by Crunchbase

Join 300K+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As: